Dark

Check out our Dark Pool Levels

BNIGF
BERONI GROUP LTD
stock OTC

Inactive

May 10, 2024

0.8200USD+15.493%(+0.1100)2,000

Pre-market

0.00USD-100.000%(-0.71)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 31, 2022

08:42AM EST Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, GlobeNewswire Inc

Nov 18, 2021

08:30AM EST Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen GlobeNewswire Inc

Oct 28, 2021

08:30AM EDT Beroni Group Published an Article Related to Single-Domain GlobeNewswire Inc

Sep 9, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has been approved by the Australian government for the annual 43.5% R&D rebate of eligible expenditure. GlobeNewswire Inc

Aug 31, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni), an Australia-based biopharmaceutical enterprise, announced the latest clinical study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) demonstrated an overall sensitivity of 95% and specificity of 100%. GlobeNewswire Inc

Aug 18, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug manufacture contract with Aurigene Pharmaceutical Services, India, a subsidiary of Dr Reddys Laboratories Limited (NYSE: RDY; BSE: 500124). GlobeNewswire Inc

May 28, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni or the Company), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. (tella) to collaborate in the field of immunotherapy for cancer treatment. GlobeNewswire Inc

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni or the Company), an Australia-based diversified biopharmaceutical enterprise today announced that it has raised US$2 million via the issue of convertible notes to an investor in Japan with the following key terms: GlobeNewswire Inc

Apr 27, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni or the Company), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2AntigenTest Kit (Colloidal Gold Method) is granted authorization for export. GlobeNewswire Inc

Feb 3, 2021

08:30AM EST Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni), an Australia-based diversified biopharmaceutical enterprise today announces that it has completed its majority acquisition of the Sydney-based anti-cancer drug development company, PENAO Pty Ltd. As a result of this acquisition, Beroni now owns 60% of PENAO Pty Ltds shares. GlobeNewswire Inc

Dec 21, 2020

08:30AM EST Beroni Groups GlobeNewswire Inc

Nov 10, 2020

08:30AM EST Beroni Group Launches a New Probiotics Health Product in China GlobeNewswire Inc

Nov 9, 2020

08:30AM EST Beroni Group Named as a Top Infection Control Solutions Company in GlobeNewswire Inc

Oct 19, 2020

08:53AM EDT Beroni Group Announces Successful Completion of GlobeNewswire Inc

Sep 8, 2020

09:30AM EDT Beroni Group Receives First Commercial Order for its COVID-19 Test GlobeNewswire Inc

Aug 12, 2020

10:34AM EDT Beroni Signs Deal With Genscript To Conduct Further Study To Develop Nanobody-based Medical Solution For COVID-19 RTTNews

09:30AM EDT Beroni Group Signs Agreement with Genscript Biotech Corporation to GlobeNewswire Inc

Aug 4, 2020

09:30AM EDT Beroni Group Has Successfully Constructed and Purified 24 Types of GlobeNewswire Inc

Share